Pharmexec Pharma Supply Chain Resilience Discussed at LogiPharma 2026
Article Content
- •Health authorities prioritize rapid adaptation over mere compliance.
- •Data analytics is crucial for identifying supply chain vulnerabilities.
- •AI and redundancy trade-offs are key topics in building resilient supply chains.
At LogiPharma 2026, experts from Pfizer and Johnson & Johnson emphasized the need for predictive strategies in supply chain management. They highlighted that health authorities are increasingly focused on how quickly organizations can adapt to disruptions rather than just compliance with quality systems. The panel discussed the importance of leveraging data to identify vulnerabilities in supply chains before issues arise. The shift from reactive to predictive approaches is critical for maintaining resilience in a volatile global market. The event featured discussions on the integration of AI and the balance between visibility and redundancy in supply chains. No specific cyber threats or vulnerabilities were reported in the articles, focusing instead on operational strategies and compliance.
Ask AI about this cluster
Answers cite the sources they use